Confirmation of Diet as a Treatment for Gulf War Illness

Recruiting Phase 3 Interventional Study
Gulf War Syndrome Gulf War Illness
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 75
Sex
Any
Trial phase
Phase 3
Study type
Interventional
Purpose
Treatment
Participants needed
160 (estimated)
Sponsor
American University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This clinical trial aims to confirm previous findings from a smaller study which demonstrated significant improvements in all symptoms among veterans with Gulf War Illness after one month on the dietary intervention. The main objectives of this study are: 1) to confirm previous findings of treatment response to the diet in a larger and more diverse group; 2) to examine how changes in the nervous s…
Trial Locations

Sorted by distance from Kentucky

Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Males and Females of all races and ethnicities who are ≤75 yrs of age * Served in the 1990-1991 Persian Gulf War * Fulfill both Center for Disease Control (CDC) and Kansas definitions of Gulf War Illness * Stable medication regimen for ≥1 month and willing to keep medications …
Contacts

Houra Taheri, PhD

202- 885-3810

htaheri@american.edu

CONTACT

Kathleen F Holton, PhD, MPH

202-885-3797

holton@american.edu

CONTACT